Table 3.
Continuation of Chemotherapy | All Patients |
With mEHT |
Without mEHT |
|||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Gemcitabine oxaliplatin | 4 | 3.8 | 1 | 2.6 | 3 | 4.5 |
Gemcitabine-carboplatin | 3 | 2.8 | 0 | 0.0 | 3 | 4.5 |
Gemcitabine abraxane | 7 | 6.6 | 5 | 12.8 | 2 | 3.0 |
Gemcitabine | 31 | 29.2 | 23 | 59.0 | 8 | 11.9 |
Folfiri or FOLFIRINOX | 7 | 6.6 | 1 | 2.6 | 6 | 9.0 |
Folfox | 8 | 7.5 | 0 | 0.0 | 8 | 11.9 |
Other | 10 | 9.4 | 3 | 7.7 | 7 | 10.4 |
No | 36 | 34.0 | 6 | 15.4 | 30 | 44.8 |
Abbreviation: mEHT, modulated electro-hyperthermia.